Filing Details
- Accession Number:
- 0001127602-10-025292
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-08 17:07:53
- Reporting Period:
- 2010-10-07
- Filing Date:
- 2010-10-08
- Accepted Time:
- 2010-10-08 17:07:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231589 | A Paul Mahon | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-10-07 | 41,488 | $28.46 | 66,988 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2010-10-07 | 10,000 | $27.97 | 76,988 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-10-07 | 51,488 | $55.29 | 25,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2010-10-07 | 41,488 | $0.00 | 41,488 | $28.46 |
Common Stock | Stock Options | Disposition | 2010-10-07 | 10,000 | $0.00 | 10,000 | $27.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
72,086 | 2007-09-15 | 2016-09-15 | No | 4 | M | Direct |
15,000 | 2008-03-15 | 2017-03-15 | No | 4 | M | Direct |
Footnotes
- This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.